SEATTLE, WA, December 20, 2016 — Cyrus Biotechnology, Inc., a new biotechnology software company offering the most advanced protein modeling and design capabilities to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is presenting at the Biotech Showcase January 9 at 5:15PM in San Francisco.
Dr. Lucas Nivon, CEO of Cyrus, will present an overview of the Cyrus Bench software package, which is already used by customers in the BioPharma and Chemical industries including many Fortune 500 firms. The presentation will show use cases based on real customer examples, and highlight the impact that Cyrus Bench can make in accelerating product discovery.
Cyrus Bench automates the Rosetta software suite developed by the RosettaCommons consortium. Bench makes the most advanced biotechnology software available to most industry users for the very first time. Cyrus customers can apply the most advanced and validated in silico protein engineering science through an intuitive user interface for:
- Protein Structure Prediction (best overall performance at CASP and CAMEO)
- Protein Stabilization (single point mutants, multiple point mutants, evolutionary redesign)
- Protein / Protein Interface Design
- Protein Design (modifications to function or structure)
- Enzyme Optimization
Cyrus Biotechnology, Inc. is a new privately-held biotechnology software company offering protein modeling and design capabilities to the Biopharmaceutical, Chemical, Consumer Products and Synthetic Biology industries. Cyrus was founded in 2014 as a spin-out from the University of Washington, and offers Bench, a Software-as-a-Service (SaaS) platform for protein structure prediction, modeling, stabilization, engineering and design to accelerate discovery of Biologics and Small Molecules. Cyrus Bench is based primarily on the Rosetta software package from Prof. David Baker’s lab at the University of Washington, along with associated software. Cyrus Bench offers the world-leading protein structure prediction pipeline of Rosetta and SparksX, the top structure prediction software in the bi-annual CASP competition and the weekly CAMEO competition, as well as the only protein engineering software experimentally proven to design new proteins completely via software. Cyrus Bench is based on over 15 years of biochemistry software development and over 400 published papers demonstrating experimental efficacy in vitro and in vivo.
NOTICE: The information contained in this document is dated as of 12/20/2016. Cyrus Biotechnology, Inc. (the Company) disclaims any obligation to update such information after such date. This document contains forward–looking statements reflecting the Company’s current expectations that necessarily involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in such forward-looking statements due to a number of factors and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.